Ex Parte Reexaminations Gain Ground: A Shift in Patent Validity Strategy

The dynamic landscape of patent validity challenges is witnessing a notable shift, as stakeholders increasingly consider ex parte reexaminations. For many years, inter partes review (IPR) has dominated this arena, preferred for its adversarial nature and the opportunity it offers challengers to participate actively in the process. Nevertheless, ex parte reexaminations are beginning to gain traction, largely due to strategic advantages that some legal professionals find compelling.

One of the primary reasons for this shift lies in the distinctive procedural elements of ex parte reexaminations. Unlike IPR, an ex parte challenge does not involve the challenger after the initial request is filed. This aspect can be appealing for those looking to reduce litigation costs and complexities, as the U.S. Patent and Trademark Office (USPTO) assumes responsibility for subsequent interactions. Furthermore, decisions resulting from an ex parte reexamination are not bound by statutory deadlines, unlike the more rigid IPR timeline.

Statistics illustrate a growing trend toward ex parte reexaminations, despite IPR’s continued prevalence. Notably, challengers have historically favored IPR, filing such petitions approximately five times more often than ex parte reexaminations, according to a recent analysis. However, the landscape is arguably evolving (see more here).

Another strategic consideration is the ability to remain anonymous in ex parte proceedings. This eliminates any retaliatory litigation risk for the challenger, which can be a significant advantage in highly competitive sectors. As a result, corporations aiming to challenge competitor patents without initiating a high-profile legal battle find ex parte reexaminations increasingly appealing.

Nevertheless, ex parte reexaminations are not devoid of limitations. For instance, they cannot correct all forms of potential errors, such as issues outside prior art. Furthermore, the USPTO, not the challenger, controls the arguments used against the patent, potentially limiting the challenge’s effectiveness if not aligned with the challenger’s strategic objectives.

Given these considerations, legal professionals and corporations must carefully assess their patent strategy toolkit. The need to weigh the benefits of a potentially less expensive, more private ex parte reexamination against the benefits of a more participative IPR process is paramount. As the industry adapts to these shifts, staying informed about the evolving legal and administrative landscape is essential for practitioners looking to navigate this complex terrain successfully.